BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 35668118)

  • 1. Expression Ratios of the Antiapoptotic BCL2 Family Members Dictate the Selective Addiction of Kaposi's Sarcoma-Associated Herpesvirus-Transformed Primary Effusion Lymphoma Cell Lines to MCL1.
    Dunham D; Viswanathan P; Gill J; Manzano M
    J Virol; 2022 Dec; 96(23):e0136022. PubMed ID: 36416587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies.
    Tantawy SI; Sarkar A; Hubner S; Tan Z; Wierda WG; Eldeib A; Zhang S; Kornblau S; Gandhi V
    Clin Cancer Res; 2023 Jan; 29(2):446-457. PubMed ID: 36346691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation.
    Thus YJ; De Rooij MFM; Swier N; Beijersbergen RL; Guikema JEJ; Kersten MJ; Eldering E; Pals ST; Kater AP; Spaargaren M
    Haematologica; 2023 Mar; 108(3):797-810. PubMed ID: 36226498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties.
    Bonneaud TL; Lefebvre CC; Nocquet L; Basseville A; Roul J; Weber H; Campone M; Juin PP; Souazé F
    Cell Death Dis; 2022 Sep; 13(9):787. PubMed ID: 36104324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-x
    Hoffmeister-Wittmann P; Mock A; Nichetti F; Korell F; Heilig CE; Scherr AL; Günther M; Albrecht T; Kelmendi E; Xu K; Nader L; Kessler A; Schmitt N; Fritzsche S; Weiler S; Sobol B; Stenzinger A; Boeck S; Westphalen CB; Schulze-Osthoff K; Trojan J; Kindler T; Weichert W; Spiekermann K; Bitzer M; Folprecht G; Illert AL; Boerries M; Klauschen F; Ochsenreither S; Siveke J; Bauer S; Glimm H; Brors B; Hüllein J; Hübschmann D; Uhrig S; Horak P; Kreutzfeldt S; Banales JM; Springfeld C; Jäger D; Schirmacher P; Roessler S; Ormanns S; Goeppert B; Fröhling S; Köhler BC
    Liver Int; 2022 Dec; 42(12):2855-2870. PubMed ID: 35983950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastomas of the digestive system in adults: A review.
    Liu Y; El Jabbour T; Somma J; Nakanishi Y; Ligato S; Lee H; Fu ZY
    World J Gastrointest Surg; 2024 Apr; 16(4):1030-1042. PubMed ID: 38690053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mcl-1 Protein and Viral Infections: A Narrative Review.
    Wyżewski Z; Stępkowska J; Kobylińska AM; Mielcarska A; Mielcarska MB
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel risk model based on anoikis: Predicting prognosis and immune infiltration in cutaneous melanoma.
    Zhou Y; Wang C; Chen Y; Zhang W; Fu Z; Li J; Zheng J; Xie M
    Front Pharmacol; 2022; 13():1090857. PubMed ID: 36726781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Molecular Characterization of the Lethal Pediatric Cancer Pancreatoblastoma.
    Isobe T; Seki M; Yoshida K; Sekiguchi M; Shiozawa Y; Shiraishi Y; Kimura S; Yoshida M; Inoue Y; Yokoyama A; Kakiuchi N; Suzuki H; Kataoka K; Sato Y; Kawai T; Chiba K; Tanaka H; Shimamura T; Kato M; Iguchi A; Hama A; Taguchi T; Akiyama M; Fujimura J; Inoue A; Ito T; Deguchi T; Kiyotani C; Iehara T; Hosoi H; Oka A; Sanada M; Tanaka Y; Hata K; Miyano S; Ogawa S; Takita J
    Cancer Res; 2018 Feb; 78(4):865-876. PubMed ID: 29233928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MCL1 as putative target in pancreatoblastoma.
    Reissig TM; Uhrig S; Jost PJ; Luchini C; Vicentini C; Liffers ST; Allgäuer M; Adsay V; Scarpa A; Lawlor RT; Fröhling S; Stenzinger A; Klöppel G; Schildhaus HU; Siveke JT
    Virchows Arch; 2022 Aug; 481(2):265-272. PubMed ID: 35668118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.
    Sio TT; Mansfield AS; Grotz TE; Graham RP; Molina JR; Que FG; Miller RC
    J Hum Genet; 2014 Mar; 59(3):124-8. PubMed ID: 24369359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of fluorescence in situ hybridization in pancreatic ductal adenocarcinoma.
    Adsay NV; Dergham ST; Koppitch FC; Dugan MC; Mohamed AN; Vaitkevicius VK; Sarkar FH
    Pancreas; 1999 Mar; 18(2):111-6. PubMed ID: 10090407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic adult pancreatoblastoma: Multimodal treatment and molecular characterization of a very rare disease.
    Berger AK; Mughal SS; Allgäuer M; Springfeld C; Hackert T; Weber TF; Naumann P; Hutter B; Horak P; Jahn A; Schröck E; Haag GM; Apostolidis L; Jäger D; Stenzinger A; Fröhling S; Glimm H; Heining C
    Pancreatology; 2020 Apr; 20(3):425-432. PubMed ID: 32156527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid cell leukemia-1 protein expression and myeloid cell leukemia-1 gene amplification in non small cell lung cancer.
    El Jabbour T; Dalvi SD; Kim S; Sheehan C; Ross JS
    Indian J Pathol Microbiol; 2018; 61(1):27-30. PubMed ID: 29567880
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.